Company Search:
Advanced Search
Sponsored Links
Kimia Farma (Persero) Tbk PT Company Snapshot
Kimia Farma (Persero) Tbk PT operates in the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Kimia Farma (Persero) Tbk PT with three other pharmaceutical manufacturers in Asia: Shenzhen Hepalink Pharmaceutical Company Limited of China (2015 sales of 2.29 billion Chinese Renmimbi [US$332.84 million] of which 100% was Pharmaceutical Manufacturing), Shandong Lukang Pharmaceutical of China (2.41 billion Chinese Renmimbi [US$350.24 million] of which 71% was Human Antibiotic), and ChangChun High New Technology Industries which is also based in China (2.37 billion Chinese Renmimbi [US$345.21 million] of which 79% was Medication).

Sales Analysis. Kimia Farma (Persero) Tbk PT reported sales of 4.86 trillion Indonesian Rupiahs (US$364.04 million) for the year ending December of 2015. This represents an increase of 7.5% versus 2014, when the company's sales were 4.52 trillion Indonesian Rupiahs. Sales at Kimia Farma (Persero) Tbk PT have increased during each of the previous five years (and since 2010, sales have increased a total of 53%). Sales of Other saw an increase that was more than double the company's growth rate: sales were up 37.5% in 2015, from 65.72 billion Indonesian Rupiahs to 90.34 billion Indonesian Rupiahs. Kimia Farma (Persero) Tbk PT also saw significant increases in sales in Retail (up 10.1% to 2.68 trillion Indonesian Rupiahs) and Manufacturing (up 24.1% to 243.02 billion Indonesian Rupiahs) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Kimia Farma (Persero) Tbk PT
  Stock Performance Chart for Kimia Farma (Persero) Tbk PT
  Stock Data: Recent Stock Performance:
  Current Price (2/17/2017): 2,000.00
(Figures in Indonesian Rupiahs)
1 Week -2.9%   13 Weeks -15.6%  
4 Weeks -8.3%   52 Weeks 77.8%  
Kimia Farma (Persero) Tbk PT Key Data:
  Ticker: KAEF Country: Indonesia
  Exchanges: JAK Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2015 Sales 4,860,371,483,524
(Year Ending Jan 2016).
Employees: 7,975
  Currency: Indonesian Rupiahs Market Cap: 11,108,000,000,000
  Fiscal Yr Ends: December Shares Outstanding: 5,554,000,000
  Share Type: Series B Closely Held Shares: 5,000,000,000
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.